• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

New vaccine to prevent calf diarrhea is launched

September 6, 2022
dvm360 Staff

The product from Boehringer Ingelheim promotes the development of antibodies against rotavirus, coronavirus, and E. coli F5 (K99) adhesin

Boehringer Ingelheim is launching a vaccine for the prevention of calf diarrhea, or calf scour, (Fencovis) which offers passive immunity to calves through the cows' maternal colostrum.

Calf scour is a sign of an array of gastrointestinal diseases with infectious and noninfectious causes impacting unweaned newborn calves.1 Because neonatal calves have immature immune systems and are incapable of producing their own antibodies, scour is difficult to manage. In fact, research from 2021 displayed that the incidence of diarrhea to be 18.5% and the most common disease seen in approximately 14,000 neonatal calves examined on 731 German dairy herds.2

Boehringer Ingelheim's new product is indicated for the active immunization of pregnant heifers and cows to promote the development of antibodies against rotavirus, coronavirus, and E. coli F5 (K99) adhesin, leading to the passive immunization of calves against neonatal diarrhea.1 These antibodies have been shown to prevent diarrhea caused by rotavirus and E. coli F5 (K99) adhesin and decrease the incidence and severity of diarrhea caused by coronavirus, in calves fed with colostrum and milk from vaccinated cows. Additionally, viral shedding in calves infected by rotavirus and coronavirus was reduced by this vaccine.

According to Boehringer Ingelheim, the company offers a holistic lean method to cattle farming via its training and support services to help veterinarians enhance calf management and ensure optimal gut and immune health.

Advertisement

“Boehringer Ingelheim will provide guidance to veterinarians for the use of lean management tools to maximize the impact of Fencovis on the farm and help farmers produce healthier and more productive calves,” said Gerald Behrens, global head of ruminants at Boehringer Ingelheim, in a company press release.1

After the latest registration studies, the new vaccine, which is a suspension for injection, has demonstrated unmatched protection using a non-oil adjuvant.1 The product comes with flexible presentations including a single dose pack. It will become available in specific markets within the European Union and in the United Kingdom.

References

  1. Boehringer Ingelheim launches Fencovis®, a new vaccine to prevent calf diarrhea. News release. News release. Boehringer Ingelheim. September 6, 2022. Accessed September 6, 2022. https://www.boehringer-ingelheim.com/animal-health/livestock/ruminants/vaccine-prevent-calf-diarrhea
  2. Horst EA, Kvidera SK, Baumgard LH. Invited review: The influence of immune activation on transition cow health and performance-A critical evaluation of traditional dogmas. J Dairy Sci. 2021;104(8):8380-8410. doi: 10.3168/jds.2021-20330.

Related Content:

Exotic Animal MedicineFDAPharmacy
Antelope calf born at Maryland Zoo
Antelope calf born at Maryland Zoo
FDA and European Union expand Mutual Recognition Agreement to include animal drugs
FDA and European Union expand Mutual Recognition Agreement to include animal drugs
Drug for acute onset of canine pancreatitis is launched on the US market
Drug for acute onset of canine pancreatitis is launched on the US market

Advertisement

Latest News

News wrap-up: This week’s headlines, plus Kansas State University College of Veterinary Medicine presents Temple Grandin, PhD, MS, with an honorary degree

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

View More Latest News
Advertisement